A detailed history of Agate Pass Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Agate Pass Investment Management, LLC holds 4,000 shares of BMY stock, worth $161,800. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,200 4.76%
Holding current value
$161,800
Previous $215,000 0.47%
% of portfolio
0.12%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$47.98 - $54.4 $9,596 - $10,880
-200 Reduced 4.76%
4,000 $216,000
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $30,334 - $33,918
-524 Reduced 11.09%
4,200 $243,000
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $253,348 - $295,344
4,724 New
4,724 $295,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Agate Pass Investment Management, LLC Portfolio

Follow Agate Pass Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agate Pass Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agate Pass Investment Management, LLC with notifications on news.